Literature DB >> 31522366

Neurocognitive impairment in type 2 diabetes mellitus.

Marianna Karvani1, P Simos2, S Stavrakaki3, D Kapoukranidou4.   

Abstract

There is emerging evidence that cognitive impairment could be a diabetes mellitus-related complication. It has been suggested that diabetic people are at increased risk of cognitive decline, since the metabolic and vascular disturbances of the disease affect brain function. Additionally, prolonged exposure to olther potential detrimental factors leads to irreversible cognitive decrements over time due to the aging process. Neurocognitive impairment signifies decreased performance in cognitive domains such as verbal and nonverbal memory, both immediate and delayed memory, executive function, attention, visuospatial and psychomotor performance, information processing speed, semantic knowledge, and language abilities. The aim of the present article is to review the existing literature on the issue of the neurocognitive decline in type 2 diabetes. A literature search of databases was performed, using as keywords "diabetes" and "cognitive impairment," and the reference list of papers so identified were examined, with only English language papers being used. Understanding and preventing diabetes-associated cognitive deficits remains a key priority for future research. It is important to ascertain whether interventions to delay diabetes onset or better control of established disease could prevent some of its adverse effects on cognitive skills.

Entities:  

Keywords:  Cognitive impairment; Type 2 diabetes

Mesh:

Year:  2019        PMID: 31522366     DOI: 10.1007/s42000-019-00128-2

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  9 in total

1.  Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies.

Authors:  Yanwei Hao; Jiaxin Li; Shengnan Yue; Shaofeng Wang; Shuangyuan Hu; Bin Li
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

2.  Brain activities of streptozotocin-induced diabetic Wistar rats treated with gliclazide: Behavioural, biochemical and histomorphology studies.

Authors:  Moses B Ekong; Francis N Odinukaeze; Amaobi C Nwonu; Christopher C Mbadugha; Agnes A Nwakanma
Journal:  IBRO Neurosci Rep       Date:  2022-04-14

3.  Dysfunctional Interaction Between the Dorsal Attention Network and the Default Mode Network in Patients With Type 2 Diabetes Mellitus.

Authors:  Yumeng Lei; Dongsheng Zhang; Fei Qi; Jie Gao; Min Tang; Kai Ai; Xuejiao Yan; Xiaoyan Lei; Zhirong Shao; Yu Su; Xiaoling Zhang
Journal:  Front Hum Neurosci       Date:  2021-12-24       Impact factor: 3.169

4.  Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.

Authors:  Arpita Chakraborty; Sumukha Hegde; Samir K Praharaj; Krishnananda Prabhu; Chhaya Patole; Ashok K Shetty; Shreemathi S Mayya; Raviraj V Acharya; H Manjunath Hande; M Mukhyaprana Prabhu; Dinesh Upadhya
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-31       Impact factor: 5.555

5.  Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study.

Authors:  Carlos Gómez-Martínez; Nancy Babio; Jordi Júlvez; Nerea Becerra-Tomás; Miguel Á Martínez-González; Dolores Corella; Olga Castañer; Dora Romaguera; Jesús Vioque; Ángel M Alonso-Gómez; Julia Wärnberg; José A Martínez; Luís Serra-Majem; Ramón Estruch; Francisco J Tinahones; José Lapetra; Xavier Pintó; Josep A Tur; José López-Miranda; Aurora Bueno-Cavanillas; José J Gaforio; Pilar Matía-Martín; Lidia Daimiel; Vicente Martín-Sánchez; Josep Vidal; Clotilde Vázquez; Emilio Ros; Søren Dalsgaard; Carmen Sayón-Orea; José V Sorlí; Rafael de la Torre; Itziar Abete; Lucas Tojal-Sierra; Francisco J Barón-López; Noelia Fernández-Brufal; Jadwiga Konieczna; Antonio García-Ríos; Emilio Sacanella; M Rosa Bernal-López; José M Santos-Lozano; Cristina Razquin; Andrea Alvarez-Sala; Albert Goday; M Angeles Zulet; Jessica Vaquero-Luna; Javier Diez-Espino; Aida Cuenca-Royo; Fernando Fernández-Aranda; Mònica Bulló; Jordi Salas-Salvadó
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-29       Impact factor: 5.555

Review 6.  Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches.

Authors:  Amandeep Singh; Manik Aggarwal; Rajat Garg; Tyler Stevens; Prabhleen Chahal
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 7.  Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations.

Authors:  Nataša R Mijailović; Katarina Vesic; Dragana Arsenijevic; Maja Milojević-Rakić; Milica M Borovcanin
Journal:  Front Cell Neurosci       Date:  2022-07-05       Impact factor: 6.147

8.  Causal Structural Covariance Network Suggesting Structural Alterations Progression in Type 2 Diabetes Patients.

Authors:  Jiang Zhang; Yuyan Liu; Xiaonan Guo; Jing Guo; Zhengcong Du; Muyuan He; Qihong Liu; Dundi Xu; Taiyuan Liu; Junran Zhang; Huijuan Yuan; Meiyun Wang; Shasha Li
Journal:  Front Hum Neurosci       Date:  2022-07-15       Impact factor: 3.473

9.  Factors associated to neurocognitive impairment in older adults living with HIV.

Authors:  Júlia Gutierrez-San-Juan; Itziar Arrieta-Aldea; Isabel Arnau-Barrés; Greta García-Escobar; Elisabet Lerma-Chipirraz; Paula Pérez-García; Agustin Marcos; Fabiola Blasco-Hernando; Alicia Gonzalez-Mena; Esperanza Cañas; Hernando Knobel; Robert Güerri-Fernández
Journal:  Eur J Med Res       Date:  2022-02-02       Impact factor: 2.175

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.